Anti-cancer Flower Power: Tel Aviv University Researchers Combat Cancer With A Jasmine-based Drug

Tel Aviv University — Could a substance from the jasmine flower hold the key to an effective new therapy to treat cancer. Prof. Eliezer Flescher of The Sackler Faculty of Medicine, Tel Aviv University thinks so. He and his colleagues have developed an anti-cancer drug based on a decade of research into the commercial applications of the compound Jasmonate, a synthetic compound derived from the flower itself. Prof. Flescher began to research the compound about a decade ago, and with his recent development of the drug, his studies have now begun to bear meaningful fruit.

Back to news